![]() |
Volumn 5, Issue 1, 2013, Pages 178-183
|
Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICANCER DRUG;
CANCER CELL LINES;
CANCER CELLS;
CELL INTERNALIZATION;
CELLULAR UPTAKE;
DOXORUBICIN HYDROCHLORIDE;
DRUG DELIVERY VEHICLES;
FLUORESCENCE-ACTIVATED CELL SORTERS;
HUMAN COLON CANCER CELLS;
HYALURONIC ACIDS;
MESOPOROUS SILICA NANOPARTICLES;
RECEPTOR-MEDIATED ENDOCYTOSIS;
TARGETED DELIVERY;
TARGETED DRUG DELIVERY;
CELL CULTURE;
CONFOCAL MICROSCOPY;
DRUG DELIVERY;
MOLECULAR BIOLOGY;
ORGANIC ACIDS;
CELLS;
ANTINEOPLASTIC ANTIBIOTIC;
DOXORUBICIN;
HERMES ANTIGEN;
HYALURONIC ACID;
NANOCAPSULE;
SILICON DIOXIDE;
ABSORPTION;
ARTICLE;
CHEMISTRY;
COLON TUMOR;
DIFFUSION;
HUMAN;
MATERIALS TESTING;
METABOLISM;
PATHOLOGY;
POROSITY;
TREATMENT OUTCOME;
TUMOR CELL LINE;
ULTRASTRUCTURE;
UPREGULATION;
ABSORPTION;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIGENS, CD44;
CELL LINE, TUMOR;
COLONIC NEOPLASMS;
DIFFUSION;
DOXORUBICIN;
HUMANS;
HYALURONIC ACID;
MATERIALS TESTING;
NANOCAPSULES;
POROSITY;
SILICON DIOXIDE;
TREATMENT OUTCOME;
UP-REGULATION;
|
EID: 84870876986
PISSN: 20403364
EISSN: 20403372
Source Type: Journal
DOI: 10.1039/c2nr32145a Document Type: Article |
Times cited : (303)
|
References (34)
|